ORKA
Oruka Therapeutics Inc.

228
Mkt Cap
$1.93B
Volume
1.26M
52W High
$42.88
52W Low
$5.49
PE Ratio
-16.78
ORKA Fundamentals
Price
$38.91
Prev Close
$38.82
Open
$38.91
50D MA
$34.01
Beta
1.12
Avg. Volume
339,262.59
EPS (Annual)
-$2.31
P/B
4.04
Rev/Employee
$0.00
$1,050.38
Loading...
Loading...
News
all
press releases
Oruka Therapeutics (NASDAQ:ORKA) Sets New 52-Week High - Still a Buy?
Oruka Therapeutics (NASDAQ:ORKA) Sets New 52-Week High - Here's What Happened...
MarketBeat·3d ago
News Placeholder
More News
News Placeholder
Oruka Therapeutics (NASDAQ:ORKA) SVP Sells $16,313.50 in Stock
Oruka Therapeutics, Inc. (NASDAQ:ORKA - Get Free Report) SVP Arjun Agarwal sold 395 shares of the stock in a transaction dated Monday, March 16th. The shares were sold at an average price of $41.30...
MarketBeat·4d ago
News Placeholder
Oruka Therapeutics (NASDAQ:ORKA) CEO Sells $71,407.70 in Stock
Oruka Therapeutics, Inc. (NASDAQ:ORKA - Get Free Report) CEO Lawrence Otto Klein sold 1,729 shares of the business's stock in a transaction dated Monday, March 16th. The shares were sold at an...
MarketBeat·4d ago
News Placeholder
Insider Selling: Oruka Therapeutics (NASDAQ:ORKA) Insider Sells 7,641 Shares of Stock
Oruka Therapeutics, Inc. (NASDAQ:ORKA - Get Free Report) insider Joana Goncalves sold 7,641 shares of the firm's stock in a transaction on Monday, March 16th. The stock was sold at an average price...
MarketBeat·4d ago
News Placeholder
Does Oruka Therapeutics, Inc. (ORKA) Have the Potential to Rally 41.51% as Wall Street Analysts Expect?
The average of price targets set by Wall Street analysts indicates a potential upside of 41.5% in Oruka Therapeutics, Inc. (ORKA). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Zacks·5d ago
News Placeholder
Oruka Therapeutics (NASDAQ:ORKA) Price Target Raised to $86.00 at Leerink Partners
Leerink Partners boosted their target price on Oruka Therapeutics from $58.00 to $86.00 and gave the company an "outperform" rating in a research report on Monday...
MarketBeat·5d ago
News Placeholder
Oruka Therapeutics, Inc. $ORKA is Fairmount Funds Management LLC's 7th Largest Position
Fairmount Funds Management LLC lifted its holdings in shares of Oruka Therapeutics, Inc. (NASDAQ:ORKA - Free Report) by 9.9% during the 3rd quarter, according to its most recent Form 13F filing with...
MarketBeat·6d ago
News Placeholder
Company News for Mar 16, 2026
Companies In The News Are: ADBE, META, NKTR, ORKA.
Zacks·6d ago
News Placeholder
Oruka Therapeutics (NASDAQ:ORKA) Raised to Hold at Wall Street Zen
Wall Street Zen raised shares of Oruka Therapeutics from a "sell" rating to a "hold" rating in a research report on Monday...
MarketBeat·6d ago
News Placeholder
Commodore Capital LP Has $33.71 Million Stake in Oruka Therapeutics, Inc. $ORKA
Commodore Capital LP increased its position in shares of Oruka Therapeutics, Inc. (NASDAQ:ORKA - Free Report) by 23.5% during the third quarter, according to its most recent filing with the...
MarketBeat·7d ago
<
1
2
...
>

Latest ORKA News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.